Compare KRT & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | HELP |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.7M | 889.9M |
| IPO Year | 2019 | 2020 |
| Metric | KRT | HELP |
|---|---|---|
| Price | $48.36 | $12.14 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $26.50 | ★ $51.50 |
| AVG Volume (30 Days) | 142.3K | ★ 1.7M |
| Earning Date | 05-07-2026 | 07-01-2026 |
| Dividend Yield | ★ 6.33% | N/A |
| EPS Growth | ★ 4.70 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $467,743,000.00 | N/A |
| Revenue This Year | $13.05 | N/A |
| Revenue Next Year | $8.11 | N/A |
| P/E Ratio | $25.89 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $20.61 | $3.76 |
| 52 Week High | $50.81 | $14.35 |
| Indicator | KRT | HELP |
|---|---|---|
| Relative Strength Index (RSI) | 54.62 | 55.39 |
| Support Level | $21.99 | $4.41 |
| Resistance Level | $50.81 | $14.35 |
| Average True Range (ATR) | 1.48 | 0.78 |
| MACD | -0.66 | -0.27 |
| Stochastic Oscillator | 10.77 | 19.81 |
Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.